About us Contacts Interactions: 118 620
Drug search by name

Urofollitropin Intramuscular, Subcutaneous, Injection and Thromboembolism

Result of checking the interaction of drug Urofollitropin Intramuscular, Subcutaneous, Injection and disease Thromboembolism for safety when used together.

Check result:
Urofollitropin Intramuscular, Subcutaneous, Injection <> Thromboembolism
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Thromboembolic events, including venous thrombophlebitis, pulmonary embolism, pulmonary infarction, cerebrovascular occlusion (stroke), and arterial occlusion resulting in loss of limb, have been reported during administration of gonadotropin therapy, both in association with and independent of the Ovarian Hyperstimulation Syndrome. Therapy with gonadotropins should be administered cautiously to patients with or predisposed to thromboembolism.

References:
  • "Product Information. Humegon (menotropins)." Organon, West Orange, NJ.
Urofollitropin Intramuscular, Subcutaneous, Injection

Generic Name: urofollitropin

Brand Name: Bravelle, Metrodin, Fertinex

Synonyms: Urofollitropin